KATRINA AKIN: Open Payments
NPI 1336674068 · DELTONA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,198 in 137 payments from 28 companies in 2025. Trend: 2023 $2,811 · 2024 $3,440 · 2025 $3,198
Food & beverage: $3,151Education: $47
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $387 |
| Novartis Pharmaceuticals Corporation | 15 | $318 |
| Vanda Pharmaceuticals Inc. | 10 | $229 |
| UCB, Inc. | 9 | $223 |
| SK Life Science, Inc. | 5 | $155 |
| Eisai Inc. | 5 | $154 |
| Otsuka America Pharmaceutical, Inc. | 7 | $152 |
| PFIZER INC. | 9 | $148 |
| Amgen Inc. | 7 | $140 |
| Janssen Biotech, Inc. | 5 | $120 |
Products named: KESIMPTA, QULIPTA, PONVORY, Leqembi, REXULTI, NURTEC ODT, CREXONT, UPLIZNA.
Industry payments across FL — which companies pay providers there.
